Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Ustianowski
A P
AP
Brighton Health Care, East Sussex, UK.
Leake
H
H
Evans
S
S
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000553:Ambulatory Care / Q000191:economics / Q000592:standards; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D002180:Candidiasis, Oral / Q000150:complications / Q000188:drug therapy*; D004941:Esophagitis / Q000150:complications / Q000188:drug therapy*; D015725:Fluconazole / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D008485:Medical Audit; D009761:Nystatin / Q000627:therapeutic use; D012189:Retrospective Studies
D000935:Antifungal Agents; D009761:Nystatin; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D007654:Ketoconazole